(온라인) 2021 대한조혈모세포이식학회 국제학술대회 (ICBMT 2021 Virtual) - 8월 26일 (1일차) : 2021-08-26
교육일자 : 2021-08-26
교육장소 : 온라인  
교육주제 : (온라인) 2021 대한조혈모세포이식학회 국제학술대회 (ICBMT 2021 Virtual) - 8월 26일 (1일차)
주최기관 : 대한조혈모세포이식학회
담당자 : 윤지현
연락처 : 070-4895-6129  
이메일 : bmt@kams.or.kr      
교육종류 : 내과, 소아청소년과, 진단검사의학과      
참석예상인원 : 600명
희망평점 : 6점  
지역 : 서울특별시
교육시간 : 7 시간 10분  
세부수강료 : 20,000원      
비고       

구분 월일 강의실 시간 교육제목  강사명(소속) 필수과목
교육시간 08-26 CH A 09:30~10:00 NGS-based MRD Monitoring Pre- and Post-Allogeneic HSCT for AML  Michael Heuser(MHH Hospital) 
교육시간 08-26 CH A 10:00~10:30 Conditioning Intensity of Allogeneic Transplantation for AML with MRD  Christopher S. Hourigan(NIH) 
교육시간 08-26 CH A 10:40~11:10 Engineering and Design for Next Generation CAR-T Cells  Sham Mailankody(MSKCC) 
교육시간 08-26 CH A 11:20~11:50 Machine Learning Research for Hematopoietic Stem Cell Transplantation  Yasuyuki Arai(Kyoto University) 
교육시간 08-26 CH A 11:50~12:20 Current Statistical Issues in Hematopoietic Cell Transplantation  Haesook T. Kim(Dana-Farber Cancer Institute) 
교육시간 08-26 CH B 12:40~13:20 Optimizing Stem Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation  Thomas Martin(University of California San Francisco) 
교육시간 08-26 CH A 13:30~14:30 Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants  Eun Sang Yi(Korea University Guro Hospital) 
교육시간 08-26 CH A 14:40~15:10 High Throughput Single Cell Analysis in AML  Koichi Takahashi(MDACC) 
교육시간 08-26 CH A 15:10~15:40 Therapeutic Implications in AML using Prospective Genomic Profiling  Omar Abdel-Wahab(MSKCC) 
교육시간 08-26 CH A 15:40~16:10 Clonal Hematopiesis of Indeterminate Potential in Transplantation  Kyoung Ha Kim(Soonchunhyang University Hospital) 
교육시간 08-26 CH A 16:30~17:00 FLT3 Inhibitor Maintenance Therapy after Allogeneic HSCT in FLT3 Mutated AML  Richard T. Maziarz(Oregon Health and Science University) 
교육시간 08-26 CH A 17:00~17:30 Maintenance Therapy (Hypomethylating Agents, Bcl2-Inhibitor, Check Point Inhibitors, and Other Novel Drugs) after Allogeneic HSCT in AML and MDS  Tapan Kadia(MDACC) 
교육시간 08-26 CH A 17:30~18:00 Treatment Strategies after Allogeneic HSCT in Relapsed ALL  Ik-Chan Song(Chungnam National University College of Medicine)